Fig. 2From: Development and evaluation of mucoadhesive bigel containing tenofovir and maraviroc for HIV prophylaxisa DSC scans of maraviroc/tenofovir bigel formulations BG A, BG B, BG C, and BG D. b FTIR spectra of maraviroc/tenofovir bigel formulations BG A, BG B, BG C, and BG DBack to article page